Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Video Versus Direct Laryngoscopy for Tracheal Intubation in Pediatric Surgery (VIDEOKIDS)

17 de septiembre de 2026 actualizado por: Manuel Taboada Muñiz, Hospital Clinico Universitario de Santiago

Videolaringoscopia frente a laringoscopia directa para intubación traqueal en cirugía pediátrica: El ensayo aleatorizado multicéntrico pragmático VIDEOKIDS.

Tracheal intubation in paediatric patients is a high-risk procedure in which failure to achieve successful intubation on the first attempt is associated with an increased risk of complications, including hypoxaemia and airway trauma. Videolaryngoscopes have been increasingly adopted in clinical practice because they improve glottic visualisation; however, evidence of their benefit in paediatric patients remains inconsistent.

The VIDEOKIDS trial is a large, pragmatic, international, multicentre, randomised controlled trial designed to compare videolaryngoscopy with direct laryngoscopy as the initial technique for tracheal intubation in paediatric patients undergoing surgery under general anaesthesia. The primary objective is to determine whether videolaryngoscopy increases the rate of successful intubation on the first attempt compared with direct laryngoscopy.

Descripción general del estudio

Descripción detallada

The purpose of this prospective, international, multicentre, randomised controlled trial is to compare videolaryngoscopy with direct laryngoscopy as the initial technique for tracheal intubation in paediatric patients undergoing elective surgery under general anaesthesia. We hypothesise that videolaryngoscopy will increase the frequency of successful intubation on the first attempt compared with direct laryngoscopy.

Eligible patients aged 0 to 16 years requiring orotracheal intubation will be randomly assigned in a 1:1 ratio to videolaryngoscopy or direct laryngoscopy for the first intubation attempt. The specific device and blade type, as well as all aspects of peri-intubation management, including patient positioning, preoxygenation, and pharmacological agents, will be determined by the attending anaesthesiologist according to local practice.

The primary outcome is successful tracheal intubation on the first attempt. Secondary outcomes include time to intubation, number of intubation attempts, glottic visualisation, need for adjunct airway devices, and intubation-related complications.

The primary analysis will follow the intention-to-treat principle. A mixed-effects logistic regression model will be used to account for centre-level variability and prespecified clinically relevant covariates.

Current evidence in paediatric populations remains inconclusive, with recent meta-analyses showing no clear improvement in first-attempt success despite better glottic visualisation with videolaryngoscopy.

The trial is expected to enrol approximately 5,600 patients across 15 to 25 hospitals in multiple countries, including Spain and Latin America. Recruitment is planned to begin in May 2026.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

5562

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Manuel Taboada Muñiz, Ph.D.
  • Número de teléfono: +34678195618
  • Correo electrónico: manutabo@yahoo.es

Ubicaciones de estudio

    • A CORUÑA
      • Santiago de Compostela, A CORUÑA, España, 15706
        • Reclutamiento
        • Hospital Clínico Universitario de Santiago de Compostela
        • Contacto:
          • Manuel Taboada Muñiz, Ph.D.
          • Número de teléfono: 0034 981950674
          • Correo electrónico: manutabo@yahoo.es
        • Contacto:

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

1 segundo a 16 horas (Niño)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Paediatric patients (age 0-16 years),
  • Undergoing elective or scheduled surgery under general anaesthesia requiring orotracheal intubation,
  • Planned tracheal intubation using either videolaryngoscopy or direct laryngoscopy as the initial technique,
  • Informed or general consent given, according to the relevant ethics committee statement,.

Exclusion Criteria:

  • Known upper airway anatomical abnormalities or clinical conditions requiring a specific intubation technique (e.g., fibreoptic intubation),
  • Requirement for emergent tracheal intubation that does not allow adequate randomisation,
  • Refusal of parents or legal guardians to participate in the study.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Cuidados de apoyo
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Comparador activo: Videolaryngoscope group

For patients assigned to the videolaryngoscope Group, the operator will use a video laryngoscope on the first laryngoscopy attempt.

For patients assigned to the videolaryngoscope Group, the operator will use a video laryngoscope on the first laryngoscopy attempt.

Comparador activo: Direct laryngoscope group

For patients assigned to the laryngoscope Group, the operator will use a Macintosh laryngoscope on the first laryngoscopy attempt.

For patients assigned to the laryngoscope Group, the operator will use a Macintosh laryngoscope on the first laryngoscopy attempt.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Number of intubations with successful tracheal intubation on the first attempt
Periodo de tiempo: Duration of procedure of procedure (minutes)

The primary outcome is successful tracheal intubation on the first attempt, defined as placement of an endotracheal tube in the trachea following a single insertion of the laryngoscope blade into the mouth, without its removal.

Duration of procedure of procedure (minutes)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Successful intubation
Periodo de tiempo: Duration of procedure (minutes)

Successful placement of a tube in the trachea

Duration of procedure (minutes)
Incidence of "easy intubation"
Periodo de tiempo: Duration of procedure (minutes)

Easy intubation is defined as a patient with modified Cormack-Lehane I-IIa glottic view and intubation on the first attempt.

Duration of procedure (minutes)
Number of laryngoscopy attempts
Periodo de tiempo: Duration of procedure (minutes)

Number of laryngoscopy attempts

Duration of procedure (minutes)
Number of attempts to cannulate the trachea with a bougie or an endotracheal tube
Periodo de tiempo: Duration of procedure (minutes)

Number of attempts to cannulate the trachea with a bougie or an endotracheal tube

Duration of procedure (minutes)
Duration of tracheal intubation
Periodo de tiempo: Duration of procedure (minutes)

The interval (in seconds) between the first insertion of a laryngoscope blade into the mouth and the final placement of an endotracheal tube in the trachea.

Duration of procedure (minutes)
Reason for failure to intubate on the first attempt
Periodo de tiempo: Duration of procedure (minutes)

Reason for failure among those who did not meet the primary outcome (successful intubation on the first attempt):

  1. Inadequate view of the larynx
  2. Inability to intubate the trachea with an endotracheal tube
  3. Inability to cannulate the trachea with a bougie
  4. Attempt aborted due to change in patient condition (e.g., worsening hypoxemia, hypotension, bradycardia, vomiting, bleeding)
  5. Technical failure of the laryngoscope (e.g., battery, light source, camera, screen)
  6. Other
Duration of procedure (minutes)
Operator-assessed difficulty of intubation
Periodo de tiempo: Duration of procedure (minutes)

Operator-assessed difficulty of intubation

  1. without difficulty
  2. mild difficulty
  3. moderate difficulty
  4. severe difficulty
Duration of procedure (minutes)
Glottic view assessed using the modified Cormack-Lehane classification
Periodo de tiempo: Duration of procedure (minutes)

Modified Cormack-Lehane grade of glottic view:

I: full view of the glottis, IIa: partial view of the glottis, IIb: arytenoid or posterior part of the vocal cords just visible, III: only epiglottis visible, IV: neither glottis nor epiglottis visible Cormack-Lehane grade of glottic view

Duration of procedure (minutes)
Glottic view assessed using the percentage of glottic opening (POGO score).
Periodo de tiempo: Duration of procedure (minutes)

The Percentage of Glottic Opening (POGO) score is defined as the percentage (0% to 100%) of the glottic opening visualised during laryngoscopy, from the anterior commissure to the interarytenoid notch. A score of 0% indicates that no glottic structures are visible, whereas 100% indicates full visualisation of the glottis.

Duration of procedure (minutes)
Need for additional airway equipment
Periodo de tiempo: Duration of procedure (minutes)

Airway equipment: bougie, stylet, other videolaryngoscope, others.

Duration of procedure (minutes)
Need to change the device for intubation
Periodo de tiempo: Duration of procedure (minutes)

Need to replace by another device, a different angled blade, requirement for a fiberoptic bronchoscope...).

Duration of procedure (minutes)

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Complications of tracheal intubation
Periodo de tiempo: From induction to 15 minutes following tracheal intubation
  1. Hypoxemia (lowest oxygen saturation measured by pulse oximetry 80%-90%),

  2. Severe hypoxemia (lowest oxygen saturation measured by pulse oximetry < 80%),

  3. Severe bradycardia:

    1. 0-3 months old: HR < 80 bpm,
    2. 4 months - 2 years: HR < 60 bpm,
    3. 2-10 years old: HR < 40 bpm,
    4. 10-16 years old: HR < 30 bpm at least 1 minute,
  4. Laryngospasm,

  5. Bronchospasm,

  6. Obstruction of tracheal tube,

  7. Airway injuries (bleeding,...),

  8. Dental injuries,

  9. Can't intubate, can't oxygenate (CICO) situation,

  10. Severe bradycardia/Cardiac arrest

  11. Pulmonary aspiration

  12. Pneumothorax/ pneumomediastinum

From induction to 15 minutes following tracheal intubation

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Manuel Taboada Muñiz, University Clinical Hospital of Santiago de Compostela

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de junio de 2026

Finalización primaria (Estimado)

30 de diciembre de 2027

Finalización del estudio (Estimado)

30 de diciembre de 2027

Fechas de registro del estudio

Enviado por primera vez

21 de marzo de 2026

Primero enviado que cumplió con los criterios de control de calidad

21 de marzo de 2026

Publicado por primera vez (Actual)

27 de marzo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

21 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

17 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

Individual participant data will not be routinely shared due to regulatory and data protection restrictions across participating countries. Data access may be considered on a case-by-case basis, subject to applicable regulations and approval by the study investigators.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir